Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas

International Journal of Cancer

Volumn 108, Issue 1, 2004, Pages 97-103

  Tiemersma, Edine W ^a   Bunschoten, Annelies ^a   Kok, Frans J ^a   Glatt, Hansruedi ^b   De Boer, Sybrand Y ^c   Kampman, Ellen ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c SLINGELAND HOSPITAL   (Netherlands)

Author keywords

Adenomatous polyps; Arylamine N acetyltransferase; Genetic predisposition to disease; Smoking; Sulfotransferase

Indexed keywords

ACYLTRANSFERASE; ALCOHOL; GLUTATHIONE TRANSFERASE; SULFOTRANSFERASE;

ACETYLATION; ADENOMA; ADULT; AGE; AGED; ARTICLE; BLOOD; CIGARETTE SMOKING; COLORECTAL TUMOR; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DNA ISOLATION; ENDOSCOPY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX; SMOKING HABIT; STATISTICAL SIGNIFICANCE;

ACETYLTRANSFERASES; ADENOMA; ADOLESCENT; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; ARYLSULFOTRANSFERASE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EPOXIDE HYDROLASES; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING; SULFOTRANSFERASES;

EID: 0345687974     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11533     Document Type: Article

References (57)

1. Giovannucci E, Martinez ME. Tobacco, colorectal cancer, and adenomas: a review of the evidence. J Natl Cancer Inst 1996;88:1717-30.
2. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-31.
3. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med 1997;26:427-34.
4. Gilissen RA, Bamforth KJ, Stavenuiter JF, Coughtrie MW, Meerman JH. Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases, Carcinogenesis 1994; 15:39-45.
5. Chou HC, Lang NP, Kadlubar FF. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res 1995;55:525-9.
6. Glatt H. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 2000; 129:141-70.
7. Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 2001;11:57-68.
8. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997;239:298-304.
9. Raftogianis RB, Wood TC, Weinshilboum RM. Human phenol sulfotransferases SULTIA2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 1999;58:605-16.
10. Glatt H, Boeing H, Engelke CEH, Kuhlow LMA, Pabel U, Pomplun D, Teubner W, Meinl W. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 2001;482:27-40.
11. Zheng W, Xie DW, Cerhan JR, Sellers TA, Wen WQ, Folsom AR. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:89-94.
12. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CD. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 1999;79:168-71.
13. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. Epoxide hydrolase Tyr113 His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 2001;10:875-82.
14. Cortessis V, Siegmund K, Chen Q, Zhou N, Diep A, Frankl H, Lee E, Zhu QS, Haile R, Levy D. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 2001;61: 2381-5.
15. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:7-32.
16. Brockton N, Little J, Sharp L, Cotton SC. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:846-61.
17. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NATI and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993;14:1633-8.
18. Glatt HR, Oesch F. Structural and metabolic parameters governing the mutagenicity of polycyclic aromatic hydrocarbons. In: De Serres FJ, ed. Chemical mutagens: principles and methods for their detection. New York: Plenum Press, 1986. 73-127.
19. Tiemersma EW, Wark PA, Ocké MC, Bunschoten A, Otten MH, Kok FJ, Kampman E. Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003;12:419-25.
20. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
21. Ocké MC. Bueno de Mesquita HB, Goddijn HE, Jansen A, Pols MA, Van Staveren WA, Kromhout D. The Dutch EPIC food frequency questionnaire: I, description of the questionnaire, and relative validity and reproducibility for food groups, Int J Epidemiol 1997;26(Suppl 1):S37-48.
22. Engelke CEH, Meinl W, Boeing H, Glatt H. Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. Pharmacogenetics 2000;10:163-9.
23. Tiemersma EW, Omer RE, Bunschoten A, Van't Veer P, Kok FJ. Idris MO, Kadaru AM, Fedail SS, Kampman E. Role of genetic polymorphism of glutathione S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2001;10:785-91.
24. Bunschoten A, Tiemersma E, Schouls L, Kampman E. Simultaneous determination of polymorphism in N-acetyltransferase 1 and 2 genes by reverse line blot hybridization. Anal Biochem 2000;285:156-62.
25. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;236:184-6.
26. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase MI (GSTMI) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
27. Bruhn C, Brockmoller J, Cascorbi I, Roots I, Borchert HH. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type I (NAT1). Biochem Pharmacol 1999;58:1759-64.
28. Assmann SF. Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology 1996;7:286-90.
29. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, Willett WC. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994;86:183-91.
30. Giovannucci E, Colditz GA. Stampfer MJ, Hunter D, Rosner BA, Willett WC, Speizer FE. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 1994;86:192-9.
31. Terry MB and Neugut AI. Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox. Am J Epidemiol 1998;147:903-10.
32. Colditz GA, Willett WC, Stampfer MJ, Sampson L, Rosner B, Hennekens CH, Speizer FE. The influence of age, relative weight, smoking, and alcohol intake on the reproducibility of a dietary questionnaire. Int J Epidemiol 1987;16:392-8.
33. Tiemersma EW. Case-control study on colorectal adenomas: recruitment of the study population and methodological considerations - meat, smoking, alcohol, and colorectal tumors, the role of genetic susceptibility. Thesis. Wageningen, the Netherlands. Wageningen University, 2002. 23-42.
34. Hoff G, Vatn MH, Larsen S. Relationship between tobacco smoking and colorectal polyps. Scand J Gastroenterol 1987;22:13-6.
35. Kikendall JW, Bowen PE, Burgess MB, Magnetti C, Woodward J, Langenberg P. Cigarettes and alcohol as independent risk factors for colonic adenomas. Gastroenterology 1989;97:660-4.
36. Monnet E, Allemand H, Farina H, Carayon P. Cigarette smoking and the risk of colorectal adenoma in men. Scand J Gastroenterol 1991; 26:758-62.
37. Zahm SH, Cocco P, Blair A. Tobacco smoking as a risk factor for colon polyps. Am J Public Health 1991;81:846-9.
38. Cope GF, Wyatt JI, Pinder IF, Lee PN, Heatley RV, Kelleher J. Alcohol consumption in patients with colorectal adenomatous polyps. Gut 1991;32:70-2.
39. Lee WC, Neugut AI, Garbowski GC, Forde KA, Treat MR, Waye JD, Fenoglio PC. Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps. Ann Epidemiol 1993;3:239-44.
40. Almendingen K, Hofstad B, Trygg K, Hoff G, Hussain A, Vatn MH. Smoking and colorectal adenomas: a case-control study. Eur J Cancer Prev 2000;9:193-203.
41. Olsen J, Kronborg O, Lynggaard J, Ewertz M. Dietary risk factors for cancer and adenomas of the large intestine: a case-control study within a screening trial in Denmark. Eur J Cancer 1994;30A:53-60.
42. Boutron MC, Faivre J, Dop MC, Quipourt V, Senesse P. Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol 1995:141:1038-46.
43. Martinez ME, McPherson RS, Annegers JF, Levin B. Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J Natl Cancer Inst 1995;87:274-9.
44. Longnecker MP, Chen MJ, Probst-Hensch NM. Harper JM, Lee ER, Frankl HD, Haile RW. Alcohol and smoking in relation to the prevalence of adenomatous colorectal polyps detected at sigmoidoscopy. Epidemiology 1996;7:275-80.
45. Potter JD, Bigler J, Fosdick L, Bostick RM, Kampman E, Chen C., Louis TA, Grambsch P. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev 1999;8:69-75.
46. Garte S, Gaspari L, Alexandrie A-K, Ambrosone C, Autrup H, Autrup, JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10: 1239-8.
47. Frame LT, Gatlin TL, Kadlubar FF, Lang NP. Metabolic differences and their impact on human disease: sulfotransferase and colorectal cancer. Environ Toxicol Pharmacol 1997;4:277-81.
48. Coughtrie MW, Gilissen RA, Shek B. Strange RC, Fryer AA, Jones PW, Bamber DE. Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 1999:337:45-9.
49. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994;3:421-8.
50. Laurenzana EM. Hassett C, Omiecinski CJ. Post-transcriptional regulation of human microsomal epoxide hydrolase. Pharmacogenetics 1998;8:157-67.
51. Pastorelli R, Guanci M, Cerri A, Negri E, LaVecchia C, Fumagalli F, Mezzetti M, Cappelli R, Panigalli T, Fanelli R, Airoldi L. Impact of inherited polymorphisms in glutathione S-transferase MI, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol Biomarkers Prev 1998;7:703-9.
52. Lin HJ, Probst-Hensch NM, Ingles SA, Han CY, Lin BK, Lee DB, Frankl HD, Lee ER, Longnecker MP, Haile RW. Glutathione transferase (GSTMI) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res 1995;55:1224-6.
53. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R, Bell DA. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996;17:1855-9.
54. Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K, Hunter DJ. Glutathione S-transferase GSTMI and GSTTI polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 1998;7:1001-5.
55. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1998;7:1079-84.
56. Lin HJ. Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, Frankl HD, Lee ER, Haile RW. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998:7:647-52.
57. Welfare MR, Cooper J, Bassendine MF, Daly AK. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the northeast of England. Carcinogenesis 1997;18:1351-4.